5 days agoNews ArticlesAMCP 2024: Key Takeaways From Leading SpeakersIPD Analytics speaks about key takeaways from the AJMC 2024 Annual Conference
Apr 18News ArticlesGene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?IPD presents at the AMCP 2024 annual meeting discussing the current promise and future potential of gene and cell therapies.
Apr 18News ArticlesPotential Generics Could Lower Prices for Oncology, Cardiovascular Drugs | AMCP 2024IPD Analytics LLC. discusses the up to 50 generics that could be approved this year, including Victoza to treat patients with diabetes.
Apr 12News ArticlesPayers Recognize the Benefits, but Still See Weight Loss Drugs through a Cost LensJeffrey Casberg of IPD Analytics LLC, talks about how payers are thinking about weight-loss drugs.